Theoretical and experimental comparison of constant inspired concentration and pulsed delivery in NO therapy

Intensive Care Medicine

Volumn 26, Issue 8, 2000, Pages 1116-1123

  Heinonen, E ^a,b   Hogman M ^a   Merilainen P ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b Datex Ohmeda Research Unit   (Finland)

Author keywords

Hypoxia; Nitric oxide; NO delivery; Pigs; Pulmonary vasoconstriction

Indexed keywords

NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL VENTILATION; CONCENTRATION RESPONSE; DRUG DELIVERY SYSTEM; DRUG UPTAKE; LUNG ARTERY PRESSURE; LUNG DEAD SPACE; LUNG MODEL; LUNG VASOCONSTRICTION; MATHEMATICAL MODEL; NONHUMAN; PULSATILE DRUG RELEASE; SWINE; VENTILATOR; VOLUMETRY;

ANIMALS; COMPUTER SIMULATION; DRUG DELIVERY SYSTEMS; MODELS, CARDIOVASCULAR; NITRIC OXIDE; PULMONARY ALVEOLI; PULMONARY WEDGE PRESSURE; REGRESSION ANALYSIS; RESPIRATION, ARTIFICIAL; RESPIRATORY MECHANICS; RESPIRATORY THERAPY; SWINE; VASODILATOR AGENTS;

EID: 0033843523     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340051326     Document Type: Article

References (24)

1. Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor
2. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide
3. Inhaled nitric oxide: A selective pulmonary vasodilator reversing human hypoxic pulmonary vasoconstriction (HPV)
4. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome
5. Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome
6. Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome
7. Variation of nitric oxide concentration during inspiration
8. Inaccuracies of nitric oxide delivery systems during adult mechanical ventilation
9. Fluctuations of inspiratory concentration of nitric oxide (NO) during mechanical ventilation
10. A delivery system for inhalation of nitric oxide evaluated with chemiluminiscence, electrochemical fuel cells, and capnography
11. Laboratory evaluation of the I-NOvent nitric oxide delivery device
12. Inhaled nitric oxide: Can we deliver?
13. Uptake of inhaled nitric oxide in acute lung injury
14. Pulsatile inhaled nitric oxide as an alternative to prostacyclin in primary pulmonary hypertension
15. A simultaneous single breath measurement of pulmonary diffusing capacity with nitric oxide and carbon monoxide
16. Conversion of inhaled nitric oxide to nitrate in man
17. Hypoxic pulmonary vasoconstriction in nonventilated lung areas contributes to differences in hemodynamic and gas exchange responses to inhalation of nitric oxide
18. Very low doses of inhaled nitric oxide induce a potent selective pulmonary vasodilatation in patients with primary pulmonary hypertension
19. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension
20. Long-term inhalation of nitric oxide for a patient with primary pulmonary hypertension
21. Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure
22. UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs